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Introduction
1,2-Dibromo-3-chloropropane (DBCP, nemagon,
fumazone, CAS No. 96-12-8), acontaminant (0.05%)
oftheflameretardanttris(2,3-dibromopropyl) phos-
phate, has been used primarily as a soil fumigant
(30 ppm) to control nematodes. DBCP can be either
injected directly into the soil or added to irrigation
water. By 1972 an estimated 5.6 million kilograms
were being used annually; in 1977 a total of377,000
kilograms were used in California, mostly on grapes
and tomatoes. By October 1979, DBCP could be
used only on pineapple crops; in March 1981, EPA
announced that manufacturers had agreed to stop
making and using the compound, except for Hawai-
ian pineapples.
Altered testicular function (reduced spermato-
genesis and infertility) has been found in employ-
ees in several plants producing or formulating
DBCP (1-6). In 1977, low sperm counts (less than
1,000,000/mL compared with a normal value of
40,000,000/mL) werefirstfound inworkers exposed
to DBCP (7). Someworkers had no sperm. Potashnik
et al. (8) reported a correlation between exposure
time and sperm density for 23 male production line
employees; exposure longer than 100 hours was
associated with azoospermia and elevated follicle-
stimulating hormone. Legator (9) has compiled a
chronology of DBCP toxicity studies from 1961 to
1978.
1,2-Dibromo-3-chloropropane (technicalgrade) was
carcinogenic by gavage to Osborne-Mendel rats and
B6C3F1 mice, causing squamous cell carcinomas of
the forestomach in both sexes of both species and
adenocarcinomas of the mammary gland in female
rats (10-12).
1,2-Dibromo-3-chloropropane (technicalgrade) was
retested by the National Cancer Institute/National
ToxicologyProgram(NCI/NTP)BioassayProgram,
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this time using the inhalation route, since workers
were being exposed to airborne DBCP and it was
considered important to determine effects by this
route.
Methods
Male and female inbred Fischer344 rats and male
and female hybrid B6C3F1 mice, obtained from the
Frederick Cancer Research Center, were used in
this study. Control and treated groups contained 50
animals ofeach sex and species. Allgroups received
Wayne Lab Blox and water ad libitum (except food
was removed during exposure periods). Chamber
control and treated groups were exposed to concen-
trations of 0, 0.6, or 3.0 ppm DBCP for 6 hr per
day, 5 days per week, for 76 to 103 weeks.
The technical grade 1,2-dibromo-3-chloropropane
(96% pure) used in the inhalation study contained
trace amounts of epichlorohydrin and 1,2-dibro-
moethane.
This carcinogenesis bioassay was conducted from
August 1976 to August 1978 at Hazleton Labora-
tories America, Inc., under a subcontract to Tracor
Jitco (prime contractor for the testing program).
All animals that died during the study or that
were killed at the end of the exposure period were
subjected to a gross necropsy and a complete
histopathological examination. Statistical analyses
of survival differences among groups were done
using life table methods (13,14). For tumor inci-
dence data pairwise comparisons were made by
Fisher's exact tests, and the significance of dose
responsetrendswasassessedbyCochran-Armitage
tests (15,16). The study design conformed to the
NCI Guidelinesfor Carcinogen Bioassay in Small
Rodents (17).
Results
Accelerated mortality occurred in both species.
Early deaths of high dose rats and mice were
associated with respiratory tract tumors; interfer-
ence with breathing and metastasis to the brain
were major contributing factors in these deaths.
Among male mice, survival was decreased in allgroups; urogenital infection appeared to be associ-
ated with their deaths. Surviving high dose rats
were killed at week 84. The remaining high dose
female mice and high and low dose male mice were
killed at week 76. Low dose rats and female mice
were killed at week 104. Corresponding control
groups were killed at weeks 105-107, with the
exception of male mice controls killed at week 80.
Increased tumor incidences were diagnosed in all
DBCP-exposed groups. These neoplastic lesions
were located principally within the respiratory
system.
Carcinomas, squamous cell carcinomas, and ade-
nocarcinomas ofthe nasal cavity and squamous cell
papillomas ofthe tongue each occurred in high dose
male rats at incidences significantly (p < 0.05)
higher than those in the corresponding controls.
Adenocarcinomas, adenomas, adenomatous polyps
and squamous cell papillomas of the nasal cavity
and adenomatous polyps of the nasal turbinates
occurred in low dose male rats with significantly (p
< 0.01) increased incidences relative to controls.
Carcinomas and adenocarcinomas of the nasal
cavity, squamous cell papillomas of the tongue,
squamous cell papillomas and carcinomas (com-
bined) ofthe pharynx, and adenomas ofthe adrenal
cortex each occurred in high dose female rats at
incidences significantly (p < 0.05) higher than those
in the corresponding controls. Also, adenomas and
squamous cell papillomas of the nasal cavity, ade-
nomas of the adrenal cortex, and fibroadenomas of
the mammary gland were increased significantly (p
< 0.05) in low dose female rats when compared
with controls.
Adenocarcinomas ofthe nasal cavity in high dose
female mice, papillary carcinomas of the lung/
bronchiole in low dose female mice, carcinomas,
squamous cell carcinomas of the nasal cavity, and
alveolar/bronchiolar adenomas or carcinomas ofthe
lung in high-dose male and female mice occurred at
incidences significantly (p < 0.05) higher than those
in the corresponding controls.
Table 1 lists those primary tumor increases
observed in rats and Table 2 records those in mice.
Otherincreasesthoughnotstatisticallysignificant
occurred in male rats (skin trichepithelioma: 0/50,
Table 1. Primary tumor increases in F344 rats exposed to 1,2-dibromo-3-chloropropane by inhalation.
Male Female
Chamber Chamber
Site/tumor control 0.6 ppm 3.0 ppm control 0.6 ppm 3.0 ppm
Adrenal gland cortical adenoma 1/49 6/49 3/48 0/50 7/50a 5/48b
Mammary gland fibroadenoma 0/50 0/50 0/49 4/50 13/50b 4/50
Nasal cavity and turbinates all 0/50 40/50d 39/49d 1/50 27/50d 42/50d
tumorsc,f
Pharynx squamous cell papilloma or 0/50 3/50 1/49 0/50 0/50 6/50b
carcinomae
Tongue squamous cell papilloma or 0/50 1/50 11/49d 0/50 4/50 9/50d
carcinoma
aGreater than controls (p < 0.01).
bGreater than controls (p < 0.05).
CDose-related trends (p < 0.001).
dGreater than controls (p < 0.001).
eDose-related trend, females (p < 0.001).
fCarcinoma, squamous cell papilloma or carcinoma, adenoma, adenocarcinoma, adenomatous polyp, and carcinosarcoma.
Table 2. Primary tumor increases in B6C3F1 mice exposed to 1,2-dibromo-3-chloropropane by inhalation.
Male Female
Chamber Chamber
Site/tumor control 0.6 ppm 3.0 ppm control 0.6 ppm 3.0 ppm
Lung/bronchus/bronchiole all tumorsad 0/41 3/40 11/45b 4/49 12/48c 18/47b
Nasal cavity all tumorsae 0/45 1/42 19/48b 0/50 11/50b 38/50b
aDose-related trends (p < 0.001).
bGreater than controls (p < 0.001).
cGreater than controls (p < 0.05).
dPapillary adenoma or carcinoma, squamous cell carcinoma, alveolar/bronchiolar adenoma or carcinoma.
eCarcinoma, squamouscellpapillomaorcarcinoma,adenocarcinoma, adenomatouspolyp,carcinosarcoma, sarcoma, keratocanthoma,
fibrosarcoma, unspecified malignant neoplasm.
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1/50, 3/49 and tunica vaginalis mesothelima: 1/50,
2/50, 5/49), in male mice (circulatory system heman-
giosarcoma: 0/45, 0/42, 3/48 and stomach squamous
cell papilloma or carcinoma: 0/37, 0/41, 3/44), and in
female mice (harderian gland adenoma: 0/50, 5/50,
1/50).
Statistically significant decreases in tumor inci-
dence were observed for male rats (hematopoietic
system leukemia orlymphoma: 6/50, 10/50, 0/49 and
pituitary chromophobe adenoma: 10/45, 7/48, 0/44),
for female rats (pituitary chromophobe adenoma:
20/50, 20/47, 2/46 and uterus endometrial stromal
polyp: 6/50, 4/49, 0/46), and for female mice (hema-
topoietic system lymphoma: 8/50, 5/50, 1/50 and
pituitary adenoma: 8/48, 1/44, 1/28).
Discussion
In other bioassays that employed feed, gavage,
or skin application as the route of administration,
DBCP was associated with increased incidences of
squamous cell carcinomas or papillomas of the
forestomach in Osborne-Mendel rats (10), Charles
Riveralbinorats (18), B6C3F1 mice (10), HAM/ICR
Swiss albino mice (18), and ICH/Ha Swiss mice
(females) (19); adenocarcinomas of the mammary
gland in Osborne-Mendel rats (females) (10); renal
tubular tumors in Charles River albino rats (18);
lung papillomas in ICR/Ha Swiss mice (females)
(19); and lung tumors in Charles River rats (18).
In a chronic skin application study and in
initiation-promotion experiments reported by Van
Duuren et al. (19), groups of 30 female ICR/Ha
Swiss mice given 11.7 or 35 mg DBCP in 0.2 mL
acetone three times per week for 62 weeks had
increased incidences of lung papillomas and squa-
mouscellcarcinomasorpapillomasoftheforestomach.
Inthese experiments, no skintumors wereinduced.
However, after skin initiation with DBCP and
promotion with phorbol myristate, animals had a
significant increase in skin tumors.
In a chronic feeding study conducted for Dow
Chemical Company in the same laboratory as the
present study, groups of 60 Charles River albino
rats and 50 HAM/ICR Swiss albino mice were fed
diets containing DBCP for 104 or 78 weeks, respec-
tively. DBCP in the diet was associated with
statistically significant increased incidences ofsqua-
mous cell carcinomas and papillomas of the fore-
stomach in the rats and mice of either sex and of
liver and renal tubular tumors in rats (18). In a
previous NCI study conducted by the same labora-
tory, DBCP administered by gavage was found to
becarcinogenicforOsborne-MendelratsandB6C3F1
mice, inducing squamous cell carcinomas of the
forestomach in rats and mice of either sex and
adenocarcinomas of the mammary gland in female
rats (10-12).
From the results of these animal bioassays,
DBCP apparently causes tumors at the direct site
ofexposure in the stomach and nasal cavity but not
on the skin. In addition, DBCP or its metabolites
cause toxic lesions and tumors at distant sites.
The contaminants of the technical grade DBCP
used in the present study included several muta-
gens, suchasepichlorohydrin(20), 1,2-dibromoethane
(21,22), and 2,3-dibromo-1-propanol (23). The third
chemical is a metabolite oftris-(2,3-dibromopropyl)-
phosphate (24,25), the carcinogen found inthe urine
of some adults and children wearing sleepwear
treated with this flame retardant (23). Epichloro-
hydrin (26) at 100 ppm and 1,2-dibromoethane (22)
at 40 or 10 ppm induced nasal tumors when inhaled.
These concentrations are considerably higher than
the concentrations of the respective chemicals to
which rats or mice in the current study were
exposed. These rats and mice may have been
exposed to a maximum level of0.021 ppm epichlo-
royhydrin. In the epichlorohydrin study, only 1 of
100 Sprague-Dawley rats exposed to 30 ppm devel-
oped nasal carcinomas. It is not likely that the nasal
tumors in the DBCP inhalation study were caused
by exposure to these contaminants, but a cocar-
cinogenic effect, however remote, cannot be ruled
out.
In other carcinogenesis studies on the related
chemical 1,2-dibromoethane (22,27), results showed
that this chemical was carcinogenic by two routes.
Administered by gavage to Osborne-Mendel rats,
1,2-dibromoethane produced squamous cell carci-
nomas of the forestomach (in males and females),
hepatocellular carcinomas (in females), and heman-
giosarcomas (in males). Administration of 1,2-dibro-
moethane by the same route to B6C3F1 mice
producedsquamouscellcarcinomasoftheforestomach
and alveolar/bronchiolar adenomas in both sexes.
When administered to F344 rats by inhalation,
1,2-dibromoethane produced a variety of nasal
cavity tumors in males and females, hemangio-
sarcomas of the circulatory system, and meso-
theliomas in the tunica vaginalis in males, and
mammary gland fibroadenomas in females. Admin-
istered by inhalation to B6C3F1 mice, 1,2-dibro-
moethaneproducedalveolar/bronchiolarcarcinomas
and adenomas in males and females and hemangio-
sarcomas of the circulatory system, subcutaneous
fibrosarcomas, tumors of the nasal cavity, and
mammary gland adenocarcinomas in females.
The direct mutagenic activity of technical grade
DBCP in bacterial systems (28) can be attributed to
contamination with epichlorohydrin (29), a direct
acting bacterial mutagen. Several investigators,
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however, have reported the mutagenic effects of
DBCP in Salmonella typhimurium following met-
abolic activation with rat liver S9 [TA 1535 (29);
TA 1530 (28); TA 100 (23)]. Because epichlorohydrin
is used as a stabilizer in DBCP, investigators must
specify the purity of DBCP samples studied.
The genetic effects ofDBCP in mammalian germ
cells havebeenreported forrats, mice, andhumans.
Lee and Suzuki (30) detected unscheduled DNA
synthesis in the premeiotic germ cells (but not
spermatozoa) of mice given a maximum tolerated
dose (100 mg/kg) intraperitoneally. DBCP was also
reported to induce dominant lethal mutations in
rats (highest dose, 50 mg/kg) but not in mice at a
high dose of 150 mg/kg (31). The dominant lethal
effects in rats were observed in postmeiotic cells,
particularly spermatids.
The available data indicate that DBCP can be
metabolized by rat liver S9 to form a bacterial
mutagen. DBCP or its metabolites are apparently
distributed to the testes and can induce genetic
damage as reflected by dominant lethal mutations
and unscheduled DNA synthesis in premeiotic
germ cells ofrodents and perhaps by an increase in
Y-chromosomal nondisjunction in humans (32).
The mechanism of DBCP toxicity in F344 rats is
currently being investigated by the National Toxi-
cology Program (33-35), with emphasis on gonadal
toxicity and carcinogenicity, and on developing
improved methodologies for monitoring exposed
populations for deleterious effects.
From these DBCP carcinogenesis bioassay data,
separate reports have been published on the carci-
nogenic effect of oral intubation (10-12, 36) on the
morphology of nasal tumors induced by inhalation
exposure in rats (37) and in mice (38), and on the
inhalation-induced lung tumors in mice (39).
In conclusion and under the conditions of this
bioassay (40), 1,2-dibromo-3-chloropropane wascar-
cinogenic for male and female F344 rats, causing
nasal cavity tumors and tumors of the tongue in
both sexes, and cortical adenomas in the adrenal
gland offemales. 1,2-Dibromo-3-chloropropane was
carcinogenic in male and female B6C3F1 mice,
inducing nasal cavity tumors and lung tumors.
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